Readings Newsletter
Become a Readings Member to make your shopping experience even easier.
Sign in or sign up for free!
You’re not far away from qualifying for FREE standard shipping within Australia
You’ve qualified for FREE standard shipping within Australia
The cart is loading…
This title is printed to order. This book may have been self-published. If so, we cannot guarantee the quality of the content. In the main most books will have gone through the editing process however some may not. We therefore suggest that you be aware of this before ordering this book. If in doubt check either the author or publisher’s details as we are unable to accept any returns unless they are faulty. Please contact us if you have any questions.
This book primarily discusses the topic of tumor suppressor genes with the help of extensive information. Significant evidence obtained from somatic cell fusion analyses reflect that a group of genes from normal cells might replace or fix a damaged function of cancer cells. Tumorigenesis that could be caused by two mutations was developed by the examination of hereditary retinoblastoma, which led to the eventual cloning of RB1 gene. Ever since, the two-hit hypothesis has helped in isolation of a number of tumor suppressor genes (TSG). Lately, the roles of epigenetic control, haploinsufficiency, and gene dosage impacts in few TSGs, like PTEN, P16 and P53, have been analyzed descriptively. Nowadays, it is commonly recognized that deregulation of growth control is one of the main hallmarks of cancer biological capabilities, and TSGs play vital roles in numerous cellular activities with the help of signaling transduction networks. This book presents a descriptive review of present understanding of TSGs, and demonstrates that the compiled TSG knowledge has given way to a novel frontier for cancer therapies.
$9.00 standard shipping within Australia
FREE standard shipping within Australia for orders over $100.00
Express & International shipping calculated at checkout
This title is printed to order. This book may have been self-published. If so, we cannot guarantee the quality of the content. In the main most books will have gone through the editing process however some may not. We therefore suggest that you be aware of this before ordering this book. If in doubt check either the author or publisher’s details as we are unable to accept any returns unless they are faulty. Please contact us if you have any questions.
This book primarily discusses the topic of tumor suppressor genes with the help of extensive information. Significant evidence obtained from somatic cell fusion analyses reflect that a group of genes from normal cells might replace or fix a damaged function of cancer cells. Tumorigenesis that could be caused by two mutations was developed by the examination of hereditary retinoblastoma, which led to the eventual cloning of RB1 gene. Ever since, the two-hit hypothesis has helped in isolation of a number of tumor suppressor genes (TSG). Lately, the roles of epigenetic control, haploinsufficiency, and gene dosage impacts in few TSGs, like PTEN, P16 and P53, have been analyzed descriptively. Nowadays, it is commonly recognized that deregulation of growth control is one of the main hallmarks of cancer biological capabilities, and TSGs play vital roles in numerous cellular activities with the help of signaling transduction networks. This book presents a descriptive review of present understanding of TSGs, and demonstrates that the compiled TSG knowledge has given way to a novel frontier for cancer therapies.